Essai en cours de recrutement = ; Essai en cours = ; Essai terminé = ; Financé par un membre IRDiRC = ; Membre d'un ERN =

Essai(s) clinique(s) national(aux)

ALLEMAGNE

Bayern
MÜNCHEN

Efficacy, Safety, and Tolerability of Fosmetpantotenate (RE-024), a Phosphopantothenate replacement therapy, in patients with Pantothenate Kinase-associated Neurodegeneration (PKAN): A Randomized, Double-blind, Placebo-Controlled Study with an Open-Label Extension (Phase III) -DE-

Friedrich-Baur-Institut

Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik

Plus de détails

Essai(s) clinique(s) multinational(aux)

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

Efficacy, Safety, and Tolerability of Fosmetpantotenate (RE-024), a Phosphopantothenate replacement therapy, in patients with Pantothenate Kinase-associated Neurodegeneration (PKAN): A Randomized, Double-blind, Placebo-Controlled Study with an Open-Label Extension

Institution: Information not provided - US

Plus de détails